Use of azo-sulfonamide for the prevention of urinary tract symptoms and bacteriuria following cystourethroscopic examination.
D000328:Adult; D000368:Aged; D000779:Anesthetics, Local; D001391:Azo Compounds / Q000627:therapeutic use; D001437:Bacteriuria / Q000517:prevention & control*; D003558:Cystoscopy / Q000009:adverse effects*; D003975:Diazepam / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D008297:Male; D008875:Middle Aged; D010621:Phenazopyridine / Q000627:therapeutic use; D010919:Placebos; D011292:Premedication; D011725:Pyridines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D014552:Urinary Tract Infections / Q000517:prevention & control
D000779:Anesthetics, Local; D001391:Azo Compounds; D004338:Drug Combinations; D010919:Placebos; D011725:Pyridines; D013420:Sulfamethoxazole; D010621:Phenazopyridine; D003975:Diazepam